Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023
VarV demonstrates a commendable safety profile. Although there was a slight increase in AEFI incidence between 2022 and 2023, common vaccine reactions were predominantly observed, and the rates of rare reactions remained very low.
Authors
- Xiang Sun (ORCID: https://orcid.org/0000-0002-0030-7016)
- Zhiguo Wang (ORCID: https://orcid.org/0000-0002-8244-8540)
- Lei Zhang (ORCID: https://orcid.org/0000-0002-0580-0889)
- Y. Liu
- Ran Hu (ORCID: https://orcid.org/0000-0001-5068-8833)
- Wen Wang (ORCID: https://orcid.org/0009-0006-0978-8393)
- Yali Fu
Institutions
- National Health and Family Planning Commission (CN)
- Jiangsu Provincial Center for Disease Control and Prevention (CN)
- Development Research Center (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1186/s12879-024-09903-y
- Citations
- 4
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Government of Jiangsu Province